Free Trial

Quest Diagnostics (DGX) Competitors

Quest Diagnostics logo
$189.15 +2.33 (+1.25%)
As of 12:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DGX vs. HSIC, MEDP, AMN, LH, DVA, CHE, CRVL, MD, CCRN, and EHC

Should you be buying Quest Diagnostics stock or one of its competitors? The main competitors of Quest Diagnostics include Henry Schein (HSIC), Medpace (MEDP), AMN Healthcare Services (AMN), Labcorp (LH), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Pediatrix Medical Group (MD), Cross Country Healthcare (CCRN), and Encompass Health (EHC).

Quest Diagnostics vs. Its Competitors

Henry Schein (NASDAQ:HSIC) and Quest Diagnostics (NYSE:DGX) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Henry Schein has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Quest Diagnostics has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500.

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 1.1% of Henry Schein shares are owned by company insiders. Comparatively, 8.2% of Quest Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Quest Diagnostics has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Henry Schein$12.67B0.60$390M$3.1020.37
Quest Diagnostics$9.87B2.14$871M$8.3522.65

In the previous week, Henry Schein had 6 more articles in the media than Quest Diagnostics. MarketBeat recorded 30 mentions for Henry Schein and 24 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 1.07 beat Henry Schein's score of 0.51 indicating that Quest Diagnostics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Henry Schein
10 Very Positive mention(s)
5 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Quest Diagnostics
17 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Henry Schein presently has a consensus target price of $76.67, indicating a potential upside of 21.43%. Quest Diagnostics has a consensus target price of $189.06, indicating a potential downside of 0.04%. Given Henry Schein's higher probable upside, equities research analysts plainly believe Henry Schein is more favorable than Quest Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Henry Schein
0 Sell rating(s)
8 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38
Quest Diagnostics
0 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.53

Quest Diagnostics has a net margin of 9.01% compared to Henry Schein's net margin of 3.05%. Quest Diagnostics' return on equity of 15.24% beat Henry Schein's return on equity.

Company Net Margins Return on Equity Return on Assets
Henry Schein3.05% 14.36% 5.52%
Quest Diagnostics 9.01%15.24%6.64%

Summary

Quest Diagnostics beats Henry Schein on 12 of the 17 factors compared between the two stocks.

Get Quest Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DGX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DGX vs. The Competition

MetricQuest DiagnosticsMED IndustryMedical SectorNYSE Exchange
Market Cap$21.16B$4.30B$6.09B$21.70B
Dividend Yield1.71%1.24%5.73%3.59%
P/E Ratio22.6630.2884.2232.41
Price / Sales2.14257.65606.1579.86
Price / Cash13.8728.4037.8624.53
Price / Book3.084.7012.304.58
Net Income$871M$197.51M$3.32B$1.01B
7 Day Performance2.64%4.30%0.42%1.22%
1 Month Performance3.86%6.07%7.68%-0.60%
1 Year Performance27.00%26.98%71.71%10.39%

Quest Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DGX
Quest Diagnostics
4.7879 of 5 stars
$189.15
+1.2%
$189.06
0.0%
+25.3%$21.16B$9.87B22.6656,000Positive News
Upcoming Earnings
Analyst Forecast
HSIC
Henry Schein
4.1554 of 5 stars
$63.00
-0.3%
$76.67
+21.7%
-13.5%$7.64B$12.77B20.3225,000Trending News
Analyst Revision
MEDP
Medpace
4.4295 of 5 stars
$527.40
+5.2%
$422.27
-19.9%
+50.4%$14.82B$2.23B39.215,900Upcoming Earnings
Analyst Forecast
AMN
AMN Healthcare Services
4.4437 of 5 stars
$19.14
+5.4%
$23.08
+20.6%
-51.0%$733.45M$2.98B-2.462,968Trending News
Short Interest ↓
Analyst Revision
LH
Labcorp
4.4669 of 5 stars
$276.37
-0.5%
$292.00
+5.7%
+30.8%$22.97B$13.01B30.5070,000Positive News
Analyst Forecast
DVA
DaVita
4.8251 of 5 stars
$123.89
-0.1%
$155.25
+25.3%
-24.0%$8.86B$13.16B12.1876,000Analyst Forecast
CHE
Chemed
4.9817 of 5 stars
$429.20
-0.2%
$578.50
+34.8%
-29.2%$6.25B$2.43B22.0715,695Positive News
CRVL
CorVel
1.0832 of 5 stars
$71.41
-1.7%
N/A-34.7%$3.66B$895.59M36.815,075News Coverage
Analyst Forecast
MD
Pediatrix Medical Group
1.8146 of 5 stars
$16.06
+1.6%
$16.79
+4.5%
+28.0%$1.40B$2.01B12.454,305Analyst Forecast
CCRN
Cross Country Healthcare
3.7057 of 5 stars
$12.50
+7.9%
$17.93
+43.4%
+3.6%$409.50M$1.34B-48.088,205
EHC
Encompass Health
4.8131 of 5 stars
$121.35
-0.7%
$139.86
+15.2%
+26.3%$12.22B$5.67B23.7540,000Positive News

Related Companies and Tools


This page (NYSE:DGX) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners